Treatment for Children's Mental Health Conditions Has Risen Above Pre-Pandemic Levels
New reporting highlights increased use of mental-health care and antidepressant treatment among young people.
Contemporary Pediatrics reported on 22 October that treatment for paediatric mental-health conditions had risen above pre-pandemic levels, with antidepressant initiation increasing sharply among girls after the COVID-19 pandemic.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Mental-health concerns among children and adolescents can include anxiety, depression, behavioural difficulties and problems related to stress. The pandemic disrupted education, social relationships, family routines and access to services, prompting ongoing research into how young people's mental-health needs have changed.
The report describes an increase in treatment for paediatric mental-health conditions compared with pre-pandemic levels, including a marked rise in antidepressant initiation among girls. Such trends can reflect several factors: changes in the prevalence or severity of symptoms, improved recognition, increased willingness to seek help, changes in access to care, or a combination of these influences.
Higher treatment rates do not automatically mean that every treated child has a more severe condition, nor do prescription trends alone establish whether treatment is appropriate or effective. Interpreting the findings requires details about the population studied, the conditions recorded and the treatments used.
Children and teenagers with persistent sadness, anxiety, withdrawal, sleep disruption or declining school performance may benefit from a professional assessment. Treatment should be individualised and may include psychotherapy, family support, medication when appropriate, or a combination of approaches. Antidepressants should be prescribed and monitored by qualified clinicians, with age-appropriate discussion of benefits and risks.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
